NCT02226991View on ClinicalTrials.gov

Effects of Steady-state Efavirenz 600 mg QD (Sustiva®) on Tipranavir Concentration at Steady-state in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

July 31, 2006

Conditions
Healthy
Interventions
DRUG

Tipranavir

DRUG

Ritonavir

DRUG

Efavirenz

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02226991 - Effects of Steady-state Efavirenz 600 mg QD (Sustiva®) on Tipranavir Concentration at Steady-state in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter